Piper Sandler Expands Biotechnology Equity Research Team with the Addition of Kelsey Goodwin
鈥淲e are excited to welcome Kelsey to the Piper Sandler platform. She brings a deep understanding and passion for our industry and builds strong relationships to serve clients. We are deeply committed to the biotechnology sector and Kelsey鈥檚 addition will only strengthen our industry leading biopharma research practice that is collaborative and energized to provide insights for our clients,鈥� said , co-head of global equities at Piper Sandler.
Prior to joining Piper Sandler, Goodwin spent seven years at Guggenheim, where she focused primarily on the oncology therapeutic area. Before Guggenheim, Kelsey worked in pharmaceutical strategy consulting for three years. Goodwin received a bachelor鈥檚 degree in biology from
鈥淚 am beyond thrilled to join Piper Sandler, a firm with a longstanding reputation not only for its excellence and high-quality research, but also for its people. I look forward to joining the exceptionally talented, hard-working, and collaborative team, and to contributing to the continued success of the firm and its clients,鈥� said Goodwin.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients AG真人官方ize the Power of Partnership庐. Securities brokerage and investment banking services are offered in the
Follow Piper Sandler: | |
漏2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall,
View source version on businesswire.com:
Nick Lawler
Tel: 212 891-8954
[email protected]
Source: Piper Sandler Companies